Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well etanercept works in treating young patients with
idiopathic pneumonia syndrome after undergoing a donor stem cell transplant. Etanercept may
be effective in treating patients with idiopathic pneumonia syndrome after undergoing a donor
stem cell transplant.